Brand name
Evotaz, the original
We didn’t find a savings card or cash price from Evotaz’s maker. Ask the pharmacy for Evotaz’s cash price. With insurance, ask what your plan charges.
Generic name: atazanavir and cobicistat
Used for: HIV
Cash price
$1,560+ for 30 tablets
Pharmacies pay about this for Evotaz; you’d pay more.
No generic is sold yet.
Evotaz, the original
We didn’t find a savings card or cash price from Evotaz’s maker. Ask the pharmacy for Evotaz’s cash price. With insurance, ask what your plan charges.
There isn’t one.
No generic is sold yet.
EVOTAZ is a two-drug combination of atazanavir, a human immunodeficiency virus (HIV-1) protease inhibitor, and cobicistat, a CYP3A inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV‑1 infection in adults and pediatric patients weighing at least 35 kg.
Limitations of Use
Use of EVOTAZ in treatment-experienced patients should be guided by the number of baseline primary protease inhibitor resistance substitutions.
Source: the FDA label for Evotaz (E.R. Squibb & Sons, L.L.C.), May 12, 2025. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/evotaz/